Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL Meeting Abstract


Authors: Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; Bernal, Y. J.; Sadelain, M.; Brentjens, R. J.
Abstract Title: Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
Meeting Title: 55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 122
Issue: 21
Meeting Dates: 2013 Dec 7-10
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-11-15
Language: English
ACCESSION: WOS:000331385002045
PROVIDER: wos
Notes: Meeting Abstract: 874 -- Source: Wos
MSK Authors
  1. Renier J Brentjens
    189 Brentjens
  2. Jae Hong Park
    132 Park
  3. Michel W J Sadelain
    453 Sadelain
  4. Isabelle C Riviere
    161 Riviere
  5. Xiuyan Wang
    62 Wang
  6. Shirley M Bartido
    34 Bartido
  7. Clare Taylor
    16 Taylor
  8. Qing He
    10 He
  9. Yvette J Bernal
    20 Bernal
  10. Jinrong Qu
    13 Qu